Barrington Research Reaffirms Outperform Rating for Henry Schein (NASDAQ:HSIC)

Barrington Research reissued their outperform rating on shares of Henry Schein (NASDAQ:HSIC) in a research report report published on Friday morning, Benzinga reports. Barrington Research currently has a $82.00 target price on the stock.

A number of other equities research analysts have also issued reports on the company. Evercore ISI cut their price target on Henry Schein from $72.00 to $70.00 and set an in-line rating for the company in a research note on Wednesday, August 7th. Baird R W raised shares of Henry Schein from a hold rating to a strong-buy rating in a research report on Monday, July 22nd. UBS Group reduced their target price on shares of Henry Schein from $75.00 to $72.00 and set a neutral rating on the stock in a research report on Wednesday, August 7th. Piper Sandler reissued an overweight rating and set a $86.00 price objective on shares of Henry Schein in a report on Friday, June 21st. Finally, Robert W. Baird cut their price objective on shares of Henry Schein from $92.00 to $82.00 and set an outperform rating on the stock in a report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of Hold and a consensus price target of $77.10.

Henry Schein Price Performance

Shares of HSIC opened at $71.15 on Friday. The company has a market capitalization of $9.11 billion, a P/E ratio of 24.04, a price-to-earnings-growth ratio of 1.88 and a beta of 0.86. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The firm has a 50 day moving average of $69.89 and a 200 day moving average of $70.31. Henry Schein has a twelve month low of $60.01 and a twelve month high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The business had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company’s quarterly revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.31 EPS. As a group, equities research analysts anticipate that Henry Schein will post 4.75 earnings per share for the current fiscal year.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.14% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Henry Schein

Several large investors have recently made changes to their positions in the stock. KBC Group NV increased its stake in Henry Schein by 163.5% during the 4th quarter. KBC Group NV now owns 521,964 shares of the company’s stock worth $39,518,000 after buying an additional 323,901 shares during the period. Everett Harris & Co. CA increased its position in shares of Henry Schein by 13.9% in the 1st quarter. Everett Harris & Co. CA now owns 119,257 shares of the company’s stock valued at $9,006,000 after purchasing an additional 14,580 shares during the last quarter. UniSuper Management Pty Ltd grew its position in shares of Henry Schein by 611.8% in the 1st quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company’s stock valued at $1,034,000 after buying an additional 11,771 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its position in shares of Henry Schein by 64.2% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock valued at $3,138,000 after buying an additional 16,241 shares during the last quarter. Finally, Artisan Partners Limited Partnership grew its position in shares of Henry Schein by 9.5% in the 4th quarter. Artisan Partners Limited Partnership now owns 292,911 shares of the company’s stock valued at $22,176,000 after buying an additional 25,378 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.